FDA Panel Rejects AstraZeneca Drug
477368
BETHESDA, Md.  - A U.S. panel of medical experts  recommended on Friday that U.S. regulators reject AstraZeneca's  AZN.L AZN.N application to sell its anti-clotting drug  Exanta.
221610
The US Food and Drug Administration denied charges it tried to suppress a safety official&#39;s findings that painkiller Vioxx, which was pulled from the market last week, raised heart attack risks.
12623
The Food and Drug Administration has told a researcher that he cannot be part of an advisory panel that will meet early next year to review the safety of a class of drugs, COX-2 inhibitors, used to treat arthritis and pain.
65596
US regulators say recent newspaper ads for AstraZeneca&#39;s Crestor, a cholesterol-lowering drug, are false or misleading. An unusual letter from the Food and Drug Administration, sent Wednesday, dismissed as
687565
NEW YORK - A US Food and Drug Administration advisory panel rejected Procter &amp; Gamble&#39;s testosterone patch to treat female sexual dysfunction.
343005
A regulatory panel&#39;s Thursday decision not to recommend approval of Proctor &amp; Gamble Co.&#39;s sex-drive patch for women slammed shares of BioSante Pharmaceuticals Inc.
707710
US medical experts on Wednesday voted unanimously against recommending approval of Inex Pharmaceuticals Corp. and Enzon Pharmaceuticals Inc.
226836
AstraZeneca Plc suffered its third setback in two months on Friday as lung cancer drug Iressa failed to help patients live longer
256773
The US Food and Drug Administration said on Friday that Senate testimony by a veteran FDA researcher regarding safety risks for five drugs does not reflect the views of the agency.
300628
US District Judge Patti B. Saris ruled against pharmaceutical companies AstraZeneca PLC , Schering-Plough Corp. , and Bristol-Myers Squibb Co. in Boston yesterday, finding them guilty of engaging in unfair and deceptive trade practices for their medication prices, according to the law firm of Hagens Berman Sobol Shapiro LLP.
691286
Drug maker AstraZeneca PLC said Friday that the Food and Drug Administration did not approve its orally taken blood thinner Exanta.
7089
Twenty-nine patients who took  AstraZeneca Plc's  anti-cholesterol drug Crestor have developed  kidney damage, a U.S. consumer group said on Friday as it  called again for a ban on the medicine.
479311
Shares in AstraZeneca Plc fell as much  as 10 percent on Friday after regulators in the United States  and Europe raised safety concerns about the Anglo-Swedish drug  maker's anti-cholesterol treatment Crestor.
410890
AstraZeneca shares have fallen more than 6 percent after a US medical panel recommended regulators reject its anti-clotting pill Exanta, a key product for the company&#39;s future growth.
233492
Shares in drug giant AstraZeneca fall after a US medical panel recommends that regulators reject its new drug Exanta.
371568
The European Union rejects Neurochem's lead drug.
687262
A U.S. advisory panel on Friday urged regulators to reject over-the-counter sales of Merck & Co. Inc.'s  cholesterol-lowering drug Mevacor.